Approval · Notice of Compliance 14928 · 2013
FENTORA: Notice of Compliance 14928
Issued November 21, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14928
- Date
- November 21, 2013
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Opioid analgesic
Products in this notice
Medicinal ingredients
- FENTANYL CITRATE 100 MCG per TAB
- FENTANYL CITRATE 200 MCG per TAB
- FENTANYL CITRATE 400 MCG per TAB
- FENTANYL CITRATE 600 MCG per TAB
- FENTANYL CITRATE 800 MCG per TAB